Related Experiment Video

Updated: Jun 19, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

STUDIES ON MENINGOCOCCUS INFECTION : III. THE ANTIGENIC COMPLEX OF THE MENINGOCOCCUS-A TYPE-SPECIFIC SUBSTANCE

G Rake1, H W Scherp

  • 1Laboratories of The Rockefeller Institute for Medical Research.

The Journal of Experimental Medicine
|October 30, 2009
PubMed

Insights

Researchers isolated type-specific substances from meningococcus bacteria. These substances differ serologically between Type II and other strains, indicating distinct chemical properties requiring further analysis.

Area of Science:

  • Microbiology
  • Immunochemistry
  • Bacterial Pathogenesis

Background:

  • Neisseria meningitidis (meningococcus) is a significant human pathogen.
  • Understanding meningococcal antigens is crucial for vaccine development and diagnostics.
  • Previous studies have characterized various components of meningococcal cells.

Purpose of the Study:

  • To isolate and characterize type-specific substances from meningococcus autolysates.
  • To investigate potential serological differences between these substances from different meningococcal types.
  • To lay the groundwork for detailed chemical analysis of these key antigens.

Main Methods:

  • Autolysis of meningococcal cultures to release cellular components.
  • Fractionation of autolysate mixtures to isolate specific substances.
  • Serological testing to compare isolated fractions across different meningococcal types (Type I, II, and III).

Main Results:

  • Three distinct fractions were isolated from meningococcal autolysates.
  • A common type-specific substance was identified in Type I and Type III meningococci.
  • A serologically distinct substance was isolated from Type II meningococcal strains.

Conclusions:

  • Meningococcal type-specific substances exhibit serological heterogeneity.
  • Type II meningococci possess a distinct type-specific antigen compared to Type I and III.
  • Further detailed chemical analysis is warranted to elucidate the structural basis of these observed differences.

More Related Videos

Induction of Leptomeningeal Cells Modification Via Intracisternal Injection05:55

Induction of Leptomeningeal Cells Modification Via Intracisternal Injection

Published on: May 7, 2020

Humanized Mouse Model to Study Bacterial Infections Targeting the Microvasculature11:40

Humanized Mouse Model to Study Bacterial Infections Targeting the Microvasculature

Published on: April 1, 2014

Related Concept Videos

Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.